200 results
Keyword Omeprazolo GIT Remove keyword
-
List item
National expert: Gitte Larsen, Danish Medicines Agency (updated)
- Declaration of interests - 39.19 KB | PDF
- Curriculum Vitae - 24.86 KB | PDF
Gitte Larsen … Gitte Larsen … Vitae Personal information Gitte Larsen Work experience … -
List item
Veterinary medicine European public assessment report (EPAR): Purevax RC
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), Cats
Date of authorisation: 23/02/2005, Revision: 16, Authorised, Last updated: 29/03/2022 -
List item
Veterinary medicine European public assessment report (EPAR): Arti-Cell Forte
chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells, Horses
Date of authorisation: 29/03/2019, Revision: 5, Authorised, Last updated: 25/10/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Kriptazen
halofuginone, Calves, newborn
Date of authorisation: 08/02/2019,
, Revision: 2, Authorised, Last updated: 20/10/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Aftovaxpur DOE
Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063., Pigs; Cattle; Sheep
Date of authorisation: 15/07/2013,
Date of refusal: 16/05/2013, Revision: 8, Authorised, Last updated: 27/03/2020 -
List item
News: European medicines regulatory network adopts EU common standard for electronic product information
Last updated: 22/02/2022EU ePI Common Standard (on GitHub) EU4Health … -
List item
Veterinary medicine European public assessment report (EPAR): Purevax RCP FeLV
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox virus (vCP97), Cats
Date of authorisation: 23/02/2005, Revision: 15, Authorised, Last updated: 07/04/2022application/pdf v-89-aa-ws1733-g_it.pdf PDF icon application/pdf … -
List item
Veterinary medicine European public assessment report (EPAR): Purevax RCPCh
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain), attenuated feline panleucopenia virus (PLI IV), Cats
Date of authorisation: 23/02/2005, Revision: 17, Authorised, Last updated: 06/04/2022 -
List item
Veterinary medicine European public assessment report (EPAR): NexGard Combo
eprinomectin, esafoxolaner, praziquantel, Cats
Date of authorisation: 06/01/2021, Revision: 1, Authorised, Last updated: 16/02/2022 -
List item
Product-information requirements (updated)
Last updated: 15/05/2023ePI Common Standard (on GitHub) The EU ePI Common Standard …
-
List item
National expert: Ilko Getov, Bulgarian Drug Agency (updated)
- Declaration of interests - 40.16 KB | PDF
- Curriculum Vitae - 36.53 KB | PDF
-
List item
National expert: Francesco Onida, Italian Medicines Agency (updated)
- Declaration of interests - 42.89 KB | PDF
- Curriculum Vitae - 66.85 KB | PDF
-
List item
National expert: Anja Schiel, Norwegian Medicines Agency (updated)
- Declaration of interests - 39.45 KB | PDF
- Curriculum Vitae - 30.06 KB | PDF
PMC5903262. Alkemade FE, Gittenberger-de Groot AC, Schiel AE, VanMunsteren … -
List item
National expert: María Estela Moreno Martín, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.35 KB | PDF
- Curriculum Vitae - 26.19 KB | PDF
Calderón A et al. Doxazosine GITS is safe and more effective … The addition of doxazosine GITS in diabetic hypertensive … -
List item
National expert: Daniel Lovell, European Medicines Agency (updated)
- Declaration of interests - 47.47 KB | PDF
- Curriculum Vitae - 65.43 KB | PDF
Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC … Hudgins A, Ilowite NT, Klein_Gitelman M, Lindsley C, Lopez Benitez … -
List item
National expert: Celia Cerrato Rivera, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 27.54 KB | PDF
Montserrat Sanchez_Cespedes, Anna Gitt, Inmaculada Spiteri, Partha … -
List item
National expert: Gabriele Balciunaite Murziene, State Medicines Control Agency (updated)
- Declaration of interests - 39.34 KB | PDF
- Curriculum Vitae - 29.51 KB | PDF
Šiatkutė, Luka; Žvirblytė, Gitana; Mištinienė, Edita; Savickienė … -
List item
Human medicine European public assessment report (EPAR): Xenical (updated)
orlistat, Obesity
Date of authorisation: 29/07/1998, Revision: 25, Authorised, Last updated: 10/05/2023 -
List item
Human medicine European public assessment report (EPAR): Lokelma
sodium zirconium cyclosilicate, Hyperkalemia
Date of authorisation: 22/03/2018, Revision: 9, Authorised, Last updated: 26/04/2023 -
List item
Human medicine European public assessment report (EPAR): Xofigo (updated)
radium (223Ra) dichloride, Prostatic Neoplasms
Date of authorisation: 13/11/2013,
, Revision: 13, Authorised, Last updated: 16/05/2023
-
List item
Human medicine European public assessment report (EPAR): Feraccru
ferric maltol, Anemia, Iron-Deficiency
Date of authorisation: 18/02/2016, Revision: 17, Authorised, Last updated: 12/12/2022 -
List item
Human medicine European public assessment report (EPAR): Elmiron
pentosan polysulfate sodium, Cystitis, Interstitial
Date of authorisation: 02/06/2017, Revision: 14, Authorised, Last updated: 15/07/2022 -
List item
Human medicine European public assessment report (EPAR): Bosulif (updated)
bosutinib (as monohydrate), Leukemia, Myeloid
Date of authorisation: 27/03/2013, Revision: 24, Authorised, Last updated: 17/05/2023 -
List item
Human medicine European public assessment report (EPAR): Vydura
Rimegepant, Migraine Disorders
Date of authorisation: 25/04/2022,, Revision: 4, Authorised, Last updated: 21/03/2023
-
List item
Human medicine European public assessment report (EPAR): Ivabradine Anpharm
ivabradine, Angina Pectoris; Heart Failure
Date of authorisation: 08/09/2015, Revision: 9, Authorised, Last updated: 28/02/2023